Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials.
Wu MA, Del GIovane C, Colombo R, Dolci G, Arquati M, Vicini R, Russo U, Ruggiero D, Coluccio V, Taino A, Franceschini E, Facchinetti P, Mighali P, Trombetta L, Tonelli F, Gabiati C, Cogliati C, D'Amico R, Marietta M; ETHYCO Study Group.
Wu MA, et al. Among authors: marietta m.
Intern Emerg Med. 2024 Jan;19(1):71-79. doi: 10.1007/s11739-023-03439-w. Epub 2023 Oct 4.
Intern Emerg Med. 2024.
PMID: 37794281
Clinical Trial.